Cancer Research:Antitumor agent can be activated by natural response ♦ Breast cancer study raises hope of therapy to stop tumor spread ♦ Researchers develop models for targeted cancer therapy

Yin and yang: Immune signaling protein has opposing roles in breast cancer development Inhibiting the immune receptor protein TLR4 may not be a wise treatment strategy in all cancers, researchers have discovered, countering previously held beliefs,

Scientists show anti-tumor agent can be activated by natural response to cell stress Scientists have found that a drug candidate with anticancer potential can be activated by one of the body’s natural responses to cellular stress. Once activated, the agent can kill prostate cancer cells

Study supports early intervention for prostate cancer patients who experience significant emotional distress Beliefs and personality traits that are associated with higher levels of distress in newly diagnosed prostate cancer patients have been identified. The findings support the value of emotional and informational support for patients and perhaps early counseling for some who are the most distressed.

Breast cancer study raises hope of therapy to stop tumor spread Scientists have discovered a trigger that allows breast cancer cells to spread to the lungs. The findings could lead to new therapies that stop the progression of breast cancer.

Researchers develop models for targeted cancer therapy The results of a recent study on targeted therapy of a specific type of brain cancer show specific progress in cancer treatment. Diffuse intrinsic pontine glioma may be one of the lesser-known forms of cancer, yet may be one of the most diabolical.